Comorbidity of attention deficit hyperactivity disorder in a patient with epilepsy: Staring down the challenge of inattention versus nonconvulsive seizures

被引:3
作者
Miller, Derryl J. [1 ,2 ,5 ]
Komanapalli, Hannah [3 ]
Dunn, David W. [2 ,4 ]
机构
[1] Indiana Univ Sch Med, Clin Neurol, 705 Riley Hosp Dr, Indianapolis, IN 46202 USA
[2] Riley Hosp Children, 705 Riley Hosp Dr, Indianapolis, IN 46202 USA
[3] Indiana Univ Sch Med, Undergraduate Med Educ, 635 Barnhill Dr, Indianapolis, IN 46202 USA
[4] Indiana Univ Sch Med, Psychiat & Neurol, 705 Riley Hosp Dr, Indianapolis, IN 46202 USA
[5] Riley Child Neurol, 705 Riley Hosp Dr, Indianapolis, IN 46202 USA
关键词
Attention deficit hyperactivity disorder; Epilepsy; Nonepileptic; Inattentiveness; Polypharmacy; DEFICIT/HYPERACTIVITY DISORDER; ANTIEPILEPTIC DRUGS; RATING-SCALE; ILAE COMMISSION; ADHD; CHILDREN; SYMPTOMS; ADOLESCENTS; MEDICATIONS; DEFINITION;
D O I
10.1016/j.ebr.2024.100651
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Epilepsy is a heterogeneous disorder of recurrent seizures which often is comorbid with anxiety, depression, attention deficit hyperactivity disorder (ADHD), intellectual disability (ID), and other psychiatric manifestations. Treating both epilepsy and behavioral symptoms from psychiatric disorders can result in polypharmacy with interactions of medications leading to both worsened efficacy of antiseizure medications due to psychotropic effects and worsening of psychiatric symptoms due to antiseizure medication side effects. We aim to suggest pragmatic strategies for the neurologist in the diagnosis and management of comorbid ADHD in patients with epilepsy based on the International League Against Epilepsy (ILAE) Pediatric Commission guidelines and additional literature review. The screening tool of choice for the symptoms of ADHD is validated in the country of practice and written in the language of the family, though various screening tools and advantages and disadvantages of each will be discussed. Once ADHD is diagnosed, recent safety data suggest that Methylphenidate, Amphetamine, and Atomoxetine are generally safe for patients with epilepsy. We present a case of a child with epilepsy and ADHD and discuss the clinical signs, symptoms, and strategies for treatment as well as when to refer to child psychiatry.
引用
收藏
页数:6
相关论文
共 58 条
  • [11] Cross-sensitivity of psychiatric and behavioral side effects with antiepileptic drug use
    Chen, Baibing
    Choi, Hyunmi
    Hirsch, Lawrence J.
    Legge, Alexander
    Buchsbaum, Richard
    Detyniecki, Kamil
    [J]. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2018, 62 : 38 - 42
  • [12] Correlation between Epilepsy and Attention Deficit Hyperactivity Disorder: A Population-Based Cohort Study
    Chou, I-Ching
    Chang, Yu-Tzu
    Chin, Zheng-Nan
    Muo, Chih-Hsin
    Sung, Fung-Chang
    Kuo, Huang-Tsung
    Tsai, Chang-Hai
    Kao, Chia-Hung
    [J]. PLOS ONE, 2013, 8 (03):
  • [13] Fetal antiepileptic drug exposure: Motor, adaptive, and emotional/behavioral functioning at age 3 years
    Cohen, Morris J.
    Meador, Kimford J.
    Browning, Nancy
    Baker, Gus A.
    Clayton-Smith, Jill
    Kalayjian, Laura A.
    Kanner, Andres
    Liporace, Joyce D.
    Pennell, Page B.
    Privitera, Michael
    Loring, David W.
    [J]. EPILEPSY & BEHAVIOR, 2011, 22 (02) : 240 - 246
  • [14] Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis
    Cortese, Samuele
    Adamo, Nicoletta
    Del Giovane, Cinzia
    Mohr-Jensen, Christina
    Hayes, Adrian J.
    Carucci, Sara
    Atkinson, Lauren Z.
    Tessari, Luca
    Banaschewski, Tobias
    Coghill, David
    Hollis, Chris
    Simonoff, Emily
    Zuddas, Alessandro
    Barbui, Corrado
    Purgato, Marianna
    Steinhausen, Hans-Christoph
    Shokraneh, Farhad
    Xia, Jun
    Cipriani, Andrea
    [J]. LANCET PSYCHIATRY, 2018, 5 (09): : 727 - 738
  • [15] Levetiracetam-associated irritability and potential role of vitamin B6 use in veterans with epilepsy
    Dreischmeier, Emma
    Zuloaga, Andrea
    Kotloski, Robert J.
    Karasov, Ariela O.
    Gidal, Barry E.
    [J]. EPILEPSY & BEHAVIOR REPORTS, 2021, 16
  • [16] Stimulant and non-stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy
    Eaton, Chris
    Yong, Kenneith
    Walter, Victoria
    Mbizvo, Gashirai K.
    Rhodes, Sinead
    Chin, Richard Fm
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (07):
  • [17] Efron Daryl, 2023, Int J Environ Res Public Health, V20, DOI 10.3390/ijerph20085430
  • [18] Epilepsy and Attention Deficit Hyperactivity Disorder: Connection, Chance, and Challenges
    Fan, Hueng-Chuen
    Chiang, Kuo-Liang
    Chang, Kuang-Hsi
    Chen, Chuan-Mu
    Tsai, Jeng-Dau
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (06)
  • [19] Seizures in Children
    Fine, Anthony
    Wirrell, Elaine C.
    [J]. PEDIATRICS IN REVIEW, 2020, 41 (07) : 321 - 347
  • [20] ILAE Official Report: A practical clinical definition of epilepsy
    Fisher, Robert S.
    Acevedo, Carlos
    Arzimanoglou, Alexis
    Bogacz, Alicia
    Cross, J. Helen
    Elger, Christian E.
    Engel, Jerome, Jr.
    Forsgren, Lars
    French, Jacqueline A.
    Glynn, Mike
    Hesdorffer, Dale C.
    Lee, B. I.
    Mathern, Gary W.
    Moshe, Solomon L.
    Perucca, Emilio
    Scheffer, Ingrid E.
    Tomson, Torbjorn
    Watanabe, Masako
    Wiebe, Samuel
    [J]. EPILEPSIA, 2014, 55 (04) : 475 - 482